Source: Virtual Congress 2021 – Advances in asthma treatment



Rating:

Share or cite this content

Citations should be made in the following way:
C. Micheletto (Verona, Italy), M. Bilò (Ancona, Italy), L. Antonicelli (Ancona, Italy), F. De Michele (Napoli, Italy), A. Musarra (Reggio Calabria, Italy), A. Vaghi (Garbagnate Milanese (MI), Italy). Triple combination therapy in severe asthma: overview from the Italian Registry Severe Asthma (IRSA). 3521

Member's Comments

No comment yet.

Related content which might interest you: COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry Source: Eur Respir J, 56 (6) 2002857; 10.1183/13993003.02857-2020 Year: 2020 Impact of bronchiectasis on severe asthma: data from the “Severe Asthma Network Italy” (SANI) registry Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 Late Breaking Abstract - Characteristics of T2-biomarker low severe asthma patients in the UK Severe Asthma Registry (UKSAR) Source: International Congress 2019 – Asthma epidemiology in the 21st century Year: 2019 Chronic oral corticosteroids use and persistent eosinophilia in severe asthma. The Belgian Severe Asthma Registry. Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 Characteristics of severe asthmatics treated with omalizumab, mepolizumab or no biotherapy. Data from the Belgian Severe Asthma Registry (BSAR). Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases Year: 2019 Severe asthma (SA) compared to non severe persistent asthma (PA) in children: An Italian on-line database Source: International Congress 2014 – Paediatric epidemiology: wheeze, asthma and other respiratory diseases Year: 2014 The German Severe Asthma Registry: Obesity is associated with asthma parameters Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 Evaluation of methotrexate in the treatment of severe asthma Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 U-BIOPRED: Clinical characteristics of children with severe asthma (SA) and severe pre-school wheeze (SPSW) Source: International Congress 2014 – More paediatric asthma Year: 2014 The impact of obesity in patients with severe asthma in the Wessex Severe Asthma Cohort (WSAC) Source: Virtual Congress 2020 – Management of allergy, asthma and COPD Year: 2020 Characterization of asthma exacerbations in outpatients – National survey Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Proportion of complete responders after one year of treatment with biologics for severe asthma - Results from the nationwide Danish Severe Asthma Register. Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases Year: 2020 White Coat Adherence in children with asthma enrolled in a comprehensive asthma management program Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Characteristics of the adult corticosteroid-dependent severe asthma in UBIOPRED consortium Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 Experience with omalizumab in patients with moderate and severe asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Effectiveness of omalizumab in Greek patients with severe allergic asthma (SAA): The SMILE study Source: International Congress 2016 – Asthma points to ponder Year: 2016 Evaluating omalizumab persistency of response after long-term therapy (XPORT) Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 The impact of depression in patients with severe asthma (SA) in the Wessex Severe Asthma Cohort (WSAC) Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020 Patterns of nonadherence in children with severe asthma Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques Year: 2016 Characteristics of the frequent exacerbator in U-BIOPRED adult severe asthma cohort Source: International Congress 2015 – Phenotyping asthma with biomarkers Year: 2015